>>Signaling Pathways>> Microbiology & Virology>> Bacterial>>Clavulanate lithium

Clavulanate lithium

Catalog No.GC38901

클라브루산 리튬은 강력한 베타-락탐아제 억제제이며 항생제로 작용합니다.

Products are for research use only. Not for human use. We do not sell to patients.

Clavulanate lithium Chemical Structure

Cas No.: 61177-44-4

Size 가격 재고 수량
5mg
US$45.00
재고 있음
10mg
US$72.00
재고 있음
25mg
US$126.00
재고 있음
50mg
US$189.00
재고 있음
100mg Please Inquire Please Inquire

Tel:(909) 407-4943 Email: sales@glpbio.com

고객 리뷰

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Clavulanate lithium is a potent β-lactamase inhibitor and acts as an antibiotic[1][2].

Clavulanate lithium has weak antibacterial activity against most organisms when administered alone, but given in combination with beta-lactam antibiotics prevents antibiotic inactivation by microbial lactamase[1].Clavulanate lithium (0.25, 0.5 mg/L) causes a relatively slow inhibition of growth, and a higher concentration (1 mg/L) is only marginally more effective than 0.5 mg/L [2]. Cell Viability Assay[2] Cell Line: L. pneumophila NCTC 1119

[1]. Reading C, et al. Clavulanic Acid: a Beta-Lactamase-Inhibiting Beta-Lactam from Streptomyces clavuligerus. Antimicrob Agents Chemother. 1977 May; 11(5): 852-857. [2]. Stokes DH, et al. Bactericidal effects of amoxycillin/clavulanic acid against intracellular Legionella pneumophila in tissue culture studies. J Antimicrob Chemother. 1989 Apr;23(4):547-56.

리뷰

Review for Clavulanate lithium

Average Rating: 5 ★★★★★ (Based on Reviews and 19 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Clavulanate lithium

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.